MHRA Drug Safety Update: December 2023

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 5 December 2023) has been published and includes articles on:

  • Aripiprazole (Abilify and generic brands): risk of pathological gambling
  • Vitamin B12 (hydroxocobalamin, cyanocobalamin): advise patients with known cobalt allergy to be vigilant for sensitivity reactions
  • Letters and medicine recalls sent to healthcare professionals in November 2023.

To see the latest MHRA Drug Safety Updates in full, visit the GOV.uk website.

Discuss pressing issues with senior figures from Community Pharmacy England and get involved in preparations for the 2026/27 CPCF negotiations.

Click Here